摘要
目的分析研究中西医结合治疗对乙肝肝硬化顽固性腹水患者的临床疗效。方法选取我院2017年2月—2018年2月收治的88例乙肝肝硬化顽固性腹水患者作为研究对象,将其随机分为对照组(n=44)和观察组(n=44),两组患者分别采用单纯西医治疗和中西医结合治疗,比较两组患者临床疗效。结果观察组和对照组患者临床总有效率分别为93.18%(41/44)、77.27%(34/44),两组相比,差异具有统计学意义(χ~2=4.42,P<0.05);且观察组患者腹水消退时间短于对照组,两组相比,差异具有统计学意义(P<0.05)。结论乙肝肝硬化顽固性腹水患者采用中西医结合治疗更有助于改善患者的临床症状,效果优于单独采用西医治疗的效果。
Objective To analyze the clinical efficacy of integrated traditional Chinese and western medicine treatment for patients with persistent ascites due to hepatitis B cirrhosis.Methods 88 patients with refractory ascites due to hepatitis B cirrhosis in our hospital from February 2017 to February 2018 were selected as the research subjects.They were randomly divided into control group(n=44)and observation group(n=44).Two groups of patients were treated by western medicine alone and integrated Chinese and Western medicine respectively,and the clinical effects of two groups were compared.Results The clinical total effective rates of the observation group and the control group were 93.18%(41/44)and 77.27%(34/44)respectively.The difference between the two groups was statistically significant(χ2=4.42,P<0.05).The time of ascites regression in the observation group was significantly shorter in the patients than in the control group,the difference between the two groups was statistically significant(P<0.05).Conclusion Patients with refractory hepatic ascites due to hepatitis B cirrhosis adopting integrated traditional Chinese and Western medicine treatment can help improve the clinical symptoms of the patients.The effect is better than the effect of using western medicine alone,and has higher clinical promotion value.
作者
赵磊
ZHAO Lei Liver(Disease,Spleen and Stomach Department,Xintai Traditional Chinese Medicine Hospital,Xintai Shandong 271200,China)
出处
《中国继续医学教育》
2018年第24期150-152,共3页
China Continuing Medical Education
关键词
乙肝
肝硬化
顽固性腹水
中西医结合
临床疗效
阿德福韦酯
hepatitis B
liver cirrhosis
intractable ascites
Chinese and Western medicine
clinical efficacy
adefovir